Patent details

EP2343299 Title: Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2343299
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP11152677.8
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
12/12/2006
Grant date:
04/11/2015
EP Publication Date:
13/07/2011
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
08/01/2016
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
04/11/2015
EP B1 Publication Date:
04/11/2015
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
11/12/2026
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
04/11/2016
 
 

 

Name:
Incyte Holdings Corporation
Address:
1801 Augustine Cut-Off, Wilmington, DE 19803, United States of America (US)

Domicile Holder

Name:
ir. F.A. Geurts c.s.
From:
04/03/2016
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
Rodgers, James D.
Address:
Landenberg, PA 19350, United States of America (US)

2

Name:
Shepard, Stacey
Address:
Voorhees, NJ 08043, United States of America (US)

3

Name:
Maduskuie, Thomas P.
Address:
Wilmington, DE 19803, United States of America (US)

4

Name:
Wang, Haisheng
Address:
Hockessin, DE 19707, United States of America (US)

5

Name:
Falahatpisheh, Nikoo
Address:
Wilmington, DE 19810, United States of America (US)

6

Name:
Rafalski, Maria
Address:
Greenville, DE 19807, United States of America (US)

7

Name:
Arvanitis, Argyrios G.
Address:
Kennett Square, PA 19348, United States of America (US)

8

Name:
Storace, Louis
Address:
Middletown, DE 19709, United States of America (US)

9

Name:
Jalluri, Ravi Kumar
Address:
Avondale, PA 19311, United States of America (US)

10

Name:
Fridman, Jordan S.
Address:
Newark, DE 19711, United States of America (US)

11

Name:
Vaddi, Krishna
Address:
Kennett Square, PA 19348, United States of America (US)

Licensee

Name:
NOVARTIS PHARMA AG
From:
04/10/2024
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)
To:

Priority

1

Priority Patent Number:
859404 P
Priority Date:
16/11/2006
Priority Country:
United States of America (US)

2

Priority Patent Number:
856872 P
Priority Date:
03/11/2006
Priority Country:
United States of America (US)

3

Priority Patent Number:
850625 P
Priority Date:
10/10/2006
Priority Country:
United States of America (US)

4

Priority Patent Number:
810231 P
Priority Date:
02/06/2006
Priority Country:
United States of America (US)

5

Priority Patent Number:
749905 P
Priority Date:
13/12/2005
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/395; A61P 17/00; A61P 35/00; A61P 37/00; C07D 471/04; C07D 487/04;

Publication

Bulletin

1

Bulletin Heading:
MED
Journal edition number:
44/24
Publication date:
30/10/2024
Description:
Other communications

2

Bulletin Heading:
EP3
Journal edition number:
10/16
Publication date:
09/03/2016
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
47/15
Publication date:
19/11/2015
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201710
Publication date:
08/03/2017
Description:
Document reprinted after correction (B8, B9)

2

Issue number:
201545
Publication date:
04/11/2015
Description:
Grant (B1)

Deed

Licence

Change Kind/ Decision Type:
New licence registration
Deed Number:
RC202401827A
Date Registered:
04/10/2024
License Effective Date:
04/10/2024
License Expiration Date:
Scope of License:
Exclusive
Deed Filer:
Freshfields Bruckhaus Deringer LLP
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Licensee(s)

Name:
NOVARTIS PHARMA AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Other

Note:

Annual Fee

Annual Fee(s) Due Date:
31/12/2025
Annual Fee Number:
20
Annual Fee Amount:
1400 Euro
Last Annual Payment Date:
14/12/2024
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
1300 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
07/03/2016 Outgoing Correspondence Outgoing Letter 1 PDF /2/2/1/3/1/0800013122/docs/ep11152677.8_3_39969l271.pdf
08/01/2016 Outgoing Correspondence Outgoing Letter 1 PDF /2/2/1/3/1/0800013122/docs/ep11152677.8_0_outgoingcorrespondence20160108110836117.pdf
08/01/2016 Incoming Correspondence Electronic Other 2 PDF /2/2/1/3/1/0800013122/docs/ep11152677.8_1_incomingcorrespondenceelectronic20160108110837345.pdf
08/01/2016 Claims Translated claims 30 PDF /2/2/1/3/1/0800013122/docs/ep11152677.8_2_claims20160108110837861.pdf
08/01/2016 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /2/2/1/3/1/0800013122/docs/ep11152677.8_4_incomingcorrespondenceelectronic20160108110838540.pdf